BeOne Medicines (ONC) Raw Materials (2024 - 2026)

BeOne Medicines (ONC) has 3 years of Raw Materials data on file, last reported at $274.2 million in Q1 2026.

• On a quarterly basis, Raw Materials changed N/A year-over-year to $274.2 million in Q1 2026; TTM through Mar 2026 was $274.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $236.2 million, up 38.46% from the prior year.
• Raw Materials for Q1 2026 stood at $274.2 million, up from $236.2 million in the prior quarter.
• Over the last five years, Raw Materials for ONC reached as high as $274.2 million in Q1 2026 and fell as low as $170.6 million in Q4 2024.
• Historically, Raw Materials has averaged $227.0 million across 3 years, with a median of $236.2 million in 2025.
• On a YoY basis, Raw Materials climbed as much as 38.46% in 2025 and fell as far as 38.46% in 2025.
• Year by year, Raw Materials stood at $170.6 million in 2024, then soared by 38.46% to $236.2 million in 2025, then advanced by 16.1% to $274.2 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $274.2 million in Q1 2026, $236.2 million in Q4 2025, and $170.6 million in Q4 2024.